Clinical Trials in Philadelphia

Showing 10441-10460 of 17,926 trials

A Study of ARRY-334543 in Patients With Advanced Cancer

NCT00278902

This is a Phase 1 study during which patients with advanced solid tumors will receive investigational study drug ARRY-334543. This study has 2 parts. In the first part, patients will receive increasing doses of study drug (2 dosing schedules will be evaluated) in order to achieve the highest dose possible that will not cause unacceptable side effects. Approximately 70 patients from the US and Canada will be enrolled in Part 1 (Completed). In the second part of the study, patients will receive the best dose(s) and schedule(s) of study drug determined from the first part of the study and will be followed to see what side effects the study drug causes and what effectiveness it has, if any, in treating the cancer. Approximately 40 patients from the US and Canada will be enrolled in Part 2 (Completed).

Advanced Cancer

Array Biopharma, now a wholly owned subsidiary of Pfizer96 participantsStarted Jan 2006

Philadelphia, Pennsylvania, United States • Nashville, Tennessee, United States • Nashville, Tennessee, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

NCT00088452

The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.

Childhood Absence EpilepsyPetit Mal EpilepsyEpilepsy+1 more

Children's Hospital Medical Center, Cincinnati453 participantsStarted Jul 2004

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +28 more locations

A Study of ARRY-334543 in Patients With Advanced Cancer

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Find Trials by Condition in Philadelphia

A Study of ARRY-142886 in Patients With Advanced Cancer

Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Single Arm on the Tolerability of Weekly Nab-paclitaxel

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients

Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate

Plexa ICD Lead Registry

Comparison of Three Therapy-Based Interventions for Preventing Depression in Adolescents

Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study

PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses

Phase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive Cancers

A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma